Medline Inc. (ETR:L10)
Germany · Delayed Price · Currency is EUR | Market Cap | 27.21B |
| Revenue (ttm) | 25.29B +12.1% |
| Net Income | 838.49M -21.4% |
| EPS | 0.99 |
| Shares Out | n/a |
| PE Ratio | 32.45 |
| Forward PE | 15.35 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 16 |
| Open | 31.80 |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | 29.60 - 32.20 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 5, 2026 |
About Medline
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam g... [Read more]
Financial Performance
In 2025, Medline's revenue was $28.43 billion, an increase of 11.47% compared to the previous year's $25.51 billion. Earnings were $1.16 billion, a decrease of -3.42%.
Financial numbers in USD Financial StatementsNews
Fire destroys massive Medline distribution facility, ABC7 News reports
A massive fire at a Medline (MDLN) Distribution Center in Tracy, California has destroyed the 1 million-square-foot medical supply distribution center, reported ABC7 News, citing Tracy Police Departme...
Medline fire impact ‘manageable’ over medium term, says William Blair
William Blair analyst Brandon Vazquez says Medline (MDLN) shares are lower on news of a fire at a distribution center in Tracy, California. The 1M square-foot facility represents 4% of…
Medline facility fire likely to disrupt near-term fulfillment, Leerink says
Leerink analyst Michael Cherny notes that yesterday afternoon, a fire broke out at Medline’s (MDLN) Tracy, CA 1 million sq. ft. distribution facility, completely engulfing the building. No injuries we...
Medline Transcript: AGM 2026
The meeting highlighted strong 2025 performance, with $2.4 billion in new customer signings and ongoing investments in technology and product innovation. All board nominees and proposals, including executive compensation and auditor ratification, were approved.
Medline Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026
Management emphasized proactive quality controls, voluntary recalls, and minimal financial impact from recent plant shutdowns. Strong Q1 growth led to raised full-year guidance, with continued investments in automation, brand penetration, and M&A. Margin improvement and long-term earnings growth are expected, supported by operational leverage and strategic capital allocation.
Medline Transcript: 46th Annual William Blair Growth Stock Conference
The company leverages a vertically integrated model and extensive distribution network to drive growth through prime vendor contracts and customer-focused product innovation. Despite recent FDA warning letters and inflationary pressures, guidance for 2026 remains strong, with continued investment in quality and supply chain resiliency.
Medline draws another US FDA warning in two months over quality lapses
The U.S. FDA issued a warning letter to medical device maker Medline over violations of manufacturing quality standards, the second such action against the company in two months.
Medline price target lowered to $45 from $57 at Baird
Baird analyst Eric Coldwell lowered the firm’s price target on Medline (MDLN) to $45 from $57 and keeps an Outperform rating on the shares. The firm lowered its target as…
Medline Stock (MDLN) Rises despite FDA Controversy — Here’s Why
Medline’s ($MDLN) shares trimmed their Tuesday losses, rising over 1% during Wednesday’s pre-market session despite the manufacturing practice controversy surrounding the medical products supply compa...
Medline Stock (MDLN) Sinks on FDA Warning over Production Practices
Medline’s ($MDLN) shares dropped about 7% on Tuesday afternoon after the U.S. health watchdog issued a warning letter to the company — a medical supply rival to Johnson & Johnson…
Medline falls after FDA warning letter over manufacturing practices
Shares of Medline (MDLN) are lower after the FDA posted a warning letter sent to the company on May 28 over “adulterated” manufacturing practices at its Waukegan, Illinois, facility. ”…
Medline warning letter ‘doesn’t look great,’ says Baird
After the FDA sent Medline (MDLN) a warning letter for multiple manufacturing contamination incidents, Baird would “admit it doesn’t look great to see another warning letter from FDA,” but expects…
Medline price target lowered to $45 from $50 at Barclays
Barclays analyst Glen Santangelo lowered the firm’s price target on Medline (MDLN) to $45 from $50 and keeps an Overweight rating on the shares. The firm says less upside to…
Medline Canada signs Prime Vendor agreement with Mohawk Medbuy
Medline (MDLN) announced that Medline Canada has signed its first Prime Vendor agreement in the country and is the first Medline Prime Vendor relationship outside the United States. The agreement…
Medline's Prime Vendor model expands outside the United States
Agreement with Mohawk Medbuy in Canada marks first-of-its-kind Prime Vendor relationship outside the U.S. NORTHFIELD, Ill., May 29, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) announced that Medline C...
Medline Inc. announces closing of upsized secondary offering of Class A common stock
NORTHFIELD, Ill., May 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that it has closed its upsized secondary offering of 72,554,594 shares of Medline Inc.'s Clas...
Medline announces participation in upcoming investor conferences
NORTHFIELD, Ill., May 27, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that members of the executive leadership team will be participating in the following investor...
MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
EscharEx ® Phase III VALUE trial advancing; interim assessment and enrollment completion expected by the end of the first quarter of 2027 First quarter revenue of $1.5 million; full-year 2026 revenue ...
Medline 72.6M share Secondary priced at $37.00
The deal size was increased to 72.6M shares of common stock from 60M shares of common stock. Goldman Sachs, Morgan Stanley, BofA and JPMorgan acted as joint book running managers…
Medline Inc. announces pricing of upsized secondary offering of Class A common stock
NORTHFIELD, Ill., May 21, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today the pricing of its upsized secondary offering of 72,554,594 shares of Medline Inc.'s Class A ...
Medline expands animal health portfolio with spay/neuter surgical packs
Ready-to-use packs help reduce prep time and improve inventory management, allowing organizations to focus more on patient care NORTHFIELD, Ill., May 20, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) an...
Medline Registration statement: Registration filing
Medline filed a registration statement on May 20, 2026, providing details about a securities offering with the SEC.
Medline files to sell 60M shares of Class A common stock for holders
Medline (MDLN) announced that certain selling stockholders affiliated with Blackstone, Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority, have commenced an und...
Medline Inc. announces launch of secondary offering of Class A common stock
NORTHFIELD, Ill., May 20, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that certain selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and...
Medline files to sell 60M shares of Class A common stock for holders
07:03 EDT Medline (MDLN) files to sell 60M shares of Class A common stock for holders